Research on myeloma has primarily focused on RANK’s role in promoting bone disease, where RANK ligand (RANKL) is secreted by myeloma and stromal cells to promote osteoclastogenesis [16]. This evidence concerns the gene TNFSF11 and plasma cell myeloma.